| # | Drug | Count |
|---|---|---|
| 0 | DEXAMETHASONE | 15 |
| 1 | DEXAMETHASONE 1.5 MG | 15 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 14 |
| 3 | ACETAMINOPHEN | 13 |
| 4 | VANCOMYCIN | 13 |
| 5 | ACETAMINOPHEN 500MG | 12 |
| 6 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 12 |
| 7 | PAIN RELIEVER | 12 |
| 8 | CYCLOPHOSPHAMIDE | 11 |
| 9 | CYCLOPHOSPHAMIDE FOR INJECTION | 11 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | MOMETASONE FUROATE MONOHYDRATE | 5 | 0.0098 |
| 1 | ANIDULAFUNGIN | 5 | 0.0031 |
| 2 | VANCOMYCIN HYDROCHLORIDE | 14 | 0.0017 |
| 3 | NITROFURANTOIN (MACROCRYSTALS) | 1 | 0.0016 |
| 4 | MINERAL OIL, PETROLATUM | 1 | 0.0015 |
| 5 | TEPLIZUMAB-MZWV | 1 | 0.0014 |
| 6 | IBRITUMOMAB TIUXETAN | 2 | 0.0013 |
| 7 | DIFLUPREDNATE OPHTHALMIC | 1 | 0.0011 |
| 8 | CARMUSTINE | 5 | 0.0011 |
| 9 | STREPTOMYCIN | 1 | 0.0009 |
| # | Drug class | Count |
|---|---|---|
| 0 | Corticosteroid [EPC] | 40 |
| 1 | Nonsteroidal Anti-inflammatory Drug [EPC] | 33 |
| 2 | Nucleoside Metabolic Inhibitor [EPC] | 22 |
| 3 | Alkylating Drug [EPC] | 19 |
| 4 | Azole Antifungal [EPC] | 18 |
| 5 | Platinum-based Drug [EPC] | 18 |
| 6 | Benzodiazepine [EPC] | 14 |
| 7 | Glycopeptide Antibacterial [EPC] | 14 |
| 8 | Vitamin C [EPC] | 13 |
| 9 | Proteasome Inhibitor [EPC] | 12 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | CD3-directed Antibody [EPC] | 1 | 0.0014 |
| 1 | Anthracycline Topoisomerase Inhibitor [EPC] | 2 | 0.0008 |
| 2 | Lipid-based Polyene Antifungal [EPC] | 8 | 0.0006 |
| 3 | Echinocandin Antifungal [EPC] | 5 | 0.0006 |
| 4 | Monobactam Antibacterial [EPC] | 1 | 0.0004 |
| 5 | CD22-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 6 | CD33-directed Immunoconjugate [EPC] | 1 | 0.0003 |
| 7 | Glycopeptide Antibacterial [EPC] | 14 | 0.0002 |
| 8 | Lipopeptide Antibacterial [EPC] | 2 | 0.0002 |
| 9 | Ergot Derivative [EPC] | 1 | 0.0002 |